The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease

Vascular Medicine (United Kingdom)

Volumn 13, Issue 4, 2008, Pages 255-262

  Joras, Majda ^a   Poredoš, Pavel ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Exercise; Flow mediated vasodilation; Ischaemia; Peripheral arterial disease; Vasodilator function

Indexed keywords

AGED; ARTICLE; BLOOD FLOW; BRACHIAL ARTERY; CASE CONTROL STUDY; ECHOGRAPHY; EXERCISE; HUMAN; HYPEREMIA; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; TIME; VASCULARIZATION; VASODILATATION;

AGED; BRACHIAL ARTERY; CASE-CONTROL STUDIES; EXERCISE; HUMANS; HYPEREMIA; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REGIONAL BLOOD FLOW; TIME FACTORS; VASODILATION;

EID: 58249093037     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X08096347     Document Type: Article

References (35)

1. Ouriel, K. Peripheral arterial disease. Lancet 2001; 358: 1257-1264.
2. Brevetti, G, Piscione, F, Silvestro, A, et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost 2003; 89: 1058-1063.
3. Brevetti, G, De Caterina, M, Martone, VD, et al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 2001; 24: 193-199.
4. Signorelli, SS, Mazzarino, MC, Di Pino, L, et al. High circulating levels of cytokines (IL-6 and TNFα), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 2003; 8: 15-19.
5. Silvestro, A, Scopacasa, F, Oliva, G, de Cristofaro, T, Iuliano, L, Brevetti, G. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 2002; 165: 277-283.
6. Silvestro, A, Schiano, V, Bucur, R, Brevetti, G, Scopacasa, F, Chiariello, M. Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication. Angiology 2006; 57: 145-154.
7. Brendle, DC, Joseph, LJO, Corretti, MC, Gardner, AW, Katzel, LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol 2001; 87: 324-329.
8. Garg, PK, Tian, L, Criqui, MH, et al. Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation 2006; 114: 242-248.
9. Gardner, AW, Poehlman, ET. Exercise rehabilitation programs for the treatment of claudication pain: a metaanalysis. JAMA 1995; 274: 975-980.
10. Gonzalez, MA, Selwyn, AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003; 115: 99S-106S.
11. Silvestro, A, Scopacasa, F, Ruocco, A, et al. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med 2003; 8: 225-232.
12. Celermajer, DS, Sorensen, KE, Bull, C, Robinson, J, Deanfield, JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-1474.
13. Healy, B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol 1990; 16: 357-358.
14. Poredoš, P, Kek, A. Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria. Am J Cardiol 2000; 86: 364-367.
15. Fontaine, R, Kim, M, Kieny, R. Die chirurgische behandlung der peripheren durchblutungsstörungen. Helv Chir Acta 1954; 5/6: 499-533.
16. Celermajer, DS, Sorensen, KE, Gooch, VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
17. Clauss, A. Gerinnungsphysiologische Schnellmetode zur Bestimmung des Fibrinogens. Acta Haemat 1957; 17: 237-246.
18. Friedewald, WT, Levy, RI, Fredrickson, DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. Ignarro, LJ, Balestrieri, ML, Napoli, C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007; 73: 326-340.
20. Stewart, KJ, Hiatt, WR, Regensteiner, JG, Hirsch, AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941-1951.
21. Brevetti, G, Silvestro, A, Schiano, V, Chiariello, M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease. Additive value of flowmediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093-2098.
22. Jarvisalo, MJ, Toikka, JO, Vasankari, T, et al. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis 1999; 147: 237-242.
23. Taneva, E, Borucki, K, Wiens, L, et al. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. Am J Cardiol 2006; 97: 1002-1006.
24. Grundy, SM, Cleeman, JI, Bairey Merz, CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004; 110: 227-239.
25. Loffredo, L, Marcoccia, A, Pignatelli, P, et al. Oxidativestress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 2007; 28: 608-612.
26. Celermajer, DS, Sorensen, KE, Spiegelhalter, DJ, Georgakopoulos, D, Robinson, J, Deanfield, JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24: 471-476.
27. Poredoš, P. Endothelial dysfunction and cardiovascular disease. Pathophysiol Haemost Thromb 2002; 32: 274-277.
28. McDermott, MM, Liu, K, Criqui, MH, et al. Ankle-brachial index and subclinical cardiac and carotid disease. The multi-ethnic study of atherosclerosis. Am J Epidemiol 2005; 162: 33-41.
29. Brevetti, G, Silvestro, A, Di Giacomo, S, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 2003; 38: 374-379.
30. Ridker, PM, Stampfer, MJ, Rifai, N. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485.
31. Blinc, A, Poredoš, P. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease. Eur J Clin Invest 2007; 37: 157-164.
32. Holvoet, P, Jenny, NS, Schreiner, PJ, Tracy, RP, Jacobs, DR. for the Multi-Ethnic Study of Atherosclerosis. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007; 194: 245-252.
33. Matsuoka, H. Endothelial dysfunction associated with oxidative stress in human. Diabetes Res Clin Pract 2001; 54: S65-S72.
34. Heitzer, T, Schlinzig, T, Krohn, K, Meinertz, T, Munzel, T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
35. Boulton, AJM, Vinik, AI, Arezzo, JC, et al. Diabetic neuropathies. A statement by the American diabetes association. Diabetes Care 2005; 28: 956-962.